Proliferation Markers in Tumours: Interpretation and Clinical Value

Journal of Clinical Pathology - United Kingdom
doi 10.1136/jcp.51.10.716
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2018English

TGFβ Isoforms and Receptors mRNA Expression in Breast Tumours: Prognostic Value and Clinical Implications

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Tumour Markers in Germ Cell Tumours.

BMJ
1986English

Value and Social Interpretation

American Journal of Sociology
SociologyPolitical Science
1915English

Use of Novel Serum Markers in Clinical Follow-Up of Sertoli-Leydig Cell Tumours

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2007English

Analysis of Proliferation Markers and P53 Expression in Gliomas of Astrocytic Origin: Relationships and Prognostic Value

Journal of Neurosurgery
SurgeryNeurology
1997English

Comparison of the Value of PCNA and Ki-67 as Markers of Cell Proliferation in Ameloblastic Tumors

Medicina Oral, Patologia Oral y Cirugia Bucal
MedicineOtorhinolaryngologySurgeryDentistry
2013English

Diagnostic Value of WT1 in Neuroepithelial Tumours

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2009English

Molecular Findings in Maxillofacial Bone Tumours and Its Diagnostic Value

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy